Journal articles on the topic 'Methods of accrual of reserve'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Methods of accrual of reserve.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Gryko, Józefa, Leszek Czapiewski, and Joanna Lizińska. "Corporate Cash Holdings and Earnings Quality – Evidence from the Stock Market in Poland." Annales Universitatis Mariae Curie-Skłodowska, sectio H – Oeconomia 58, no. 1 (2024): 125–44. http://dx.doi.org/10.17951/h.2024.58.1.125-144.
Full textSwinnen, L. J., C. Rankin, E. J. Rushing, H. F. Laura, D. M. Damek, and G. R. Barger. "Phase II study of hydroxyurea for unresectable meningioma (Southwest Oncology Group S9811)." Journal of Clinical Oncology 27, no. 15_suppl (2009): 2063. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.2063.
Full textQueiros, Dorothy Ruth, Regis Musavengane, and Kevin Mearns. "Relationship matters in conservation: Mnqobokazi community and Phinda Private Game Reserve, South Africa." Journal of Infrastructure, Policy and Development 8, no. 14 (2024): 9342. http://dx.doi.org/10.24294/jipd9342.
Full textHanes, Douglas. "Why Does Cognitive Reserve Align With Modern Western Ideals of Success? Theoretical & Methodological Proposals." Innovation in Aging 5, Supplement_1 (2021): 705. http://dx.doi.org/10.1093/geroni/igab046.2640.
Full textIhle, Andreas, Michel Oris, Julia Sauter, Ulrike Rimmele, and Matthias Kliegel. "Cognitive Reserve and Social Capital Accrued in Early and Midlife Moderate the Relation of Psychological Stress to Cognitive Performance in Old Age." Dementia and Geriatric Cognitive Disorders 45, no. 3-4 (2018): 190–97. http://dx.doi.org/10.1159/000488052.
Full textShchepot’ev, A. V. "Financial Methods for Equating with Some Categories of the Organization’s Obligations to its Own Funds." Finance: Theory and Practice 26, no. 6 (2022): 156–65. http://dx.doi.org/10.26794/2587-5671-2022-26-6-156-165.
Full textThakkar, S., T. Hutson, J. Garcia, J. Rothaermal, M. Bart, and R. Dreicer. "A phase II trial of gemcitabine and docetaxel in hormone-refractory metastatic prostate cancer." Journal of Clinical Oncology 24, no. 18_suppl (2006): 14501. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.14501.
Full textМадиева, К. С., Г. Т. Хасенова, И. С. Нуржанова, K. Madiyeva, G. Khassenova, and I. Nurzhanova. "Keeping records and the need to create a reserve for payment of the next vacation." Вестник Казахского университета экономики, финансов и международной торговли, no. 3(40) (September 25, 2020): 132–40. http://dx.doi.org/10.52260/2304-7216.2020.3(40).15.
Full textBinti Nono, Latifah, and Siti Khomsatun. "The Relationship of Reserve Account Disclosure Transparency and Accrual Earning Management with Audit Quality as Moderating." Jurnal Dinamika Akuntansi 10, no. 1 (2018): 58–70. http://dx.doi.org/10.15294/jda.v10i1.13183.
Full textGiuliani, F., A. Febbraro, R. Addeo, et al. "Sorafenib plus cisplatin and gemcitabine in the treatment of advanced hepatocellular carcinoma (HCC): A phase II study by the Gruppo Oncologico dell'Italia Meridionale (prot. GOIM 2705)." Journal of Clinical Oncology 29, no. 4_suppl (2011): 225. http://dx.doi.org/10.1200/jco.2011.29.4_suppl.225.
Full textDouglas, Emily, Nathaniel O’Connell, Mary Hackney, et al. "Abstract OT2-01-05: The CROWN Study (CaRdiac Outcomes With Near complete estrogen deprivation): A multicenter, prospective cohort study of cardiovascular outcomes in premenopausal women treated with ovarian suppression and an aromatase inhibitor." Cancer Research 83, no. 5_Supplement (2023): OT2–01–05—OT2–01–05. http://dx.doi.org/10.1158/1538-7445.sabcs22-ot2-01-05.
Full textLicitra, Lisa, Cesare Grandi, Marco Guzzo, et al. "Primary Chemotherapy in Resectable Oral Cavity Squamous Cell Cancer: A Randomized Controlled Trial." Journal of Clinical Oncology 21, no. 2 (2003): 327–33. http://dx.doi.org/10.1200/jco.2003.06.146.
Full textWeston, Emma, Matthew Nagy, Tiwaloluwa A. Ajibewa, Molly O’Sullivan, Shannon Block, and Rebecca E. Hasson. "Acute Effects of Interrupting Prolonged Sitting With Intermittent Physical Activity on Blood Pressure in Preadolescent Children." Pediatric Exercise Science 31, no. 4 (2019): 408–15. http://dx.doi.org/10.1123/pes.2018-0224.
Full textWerutsky, Gustavo, Tomás Reinert, Daniela D. Rosa, et al. "Abstract OT3-07-01: Real-World Data on First-line Treatment of HR-positive, HER2-negative, Metastatic Breast Cancer in Brazil (BRAVE Study/LACOG 0221)." Cancer Research 83, no. 5_Supplement (2023): OT3–07–01—OT3–07–01. http://dx.doi.org/10.1158/1538-7445.sabcs22-ot3-07-01.
Full textKumar, Vinod, Nusrat Jahan, Gabrielle B. Rocque, et al. "Abstract P3-10-18: Phase II Single Arm Trial of Low Dose Capecitabine in Patients with Advanced Breast Cancer (NCT06105684)." Clinical Cancer Research 31, no. 12_Supplement (2025): P3–10–18—P3–10–18. https://doi.org/10.1158/1557-3265.sabcs24-p3-10-18.
Full textReinert, Tomás, Cristiano P. Souza, Pedro Liedke, et al. "Abstract OT2-22-02: Sequencing of anthracyclines and taxanes during neoadjuvant therapy of locally advanced HER2-negative breast cancer (NEOSAMBA Study/LACOG 0419)." Cancer Research 83, no. 5_Supplement (2023): OT2–22–02—OT2–22–02. http://dx.doi.org/10.1158/1538-7445.sabcs22-ot2-22-02.
Full textPerry, J. R., T. Cloughesy, D. A. Berry, et al. "KS03.5.A EVALUATION OF VAL-083 IN GBM AGILE, A PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA." Neuro-Oncology 26, Supplement_5 (2024): v5. http://dx.doi.org/10.1093/neuonc/noae144.013.
Full textMcSorley, James C. "Analysis of ESAC-Net/EARS-Net Data from 29 EEA Countries for Spatiotemporal Associations Between Antimicrobial Use and Resistance—Implications for Antimicrobial Stewardship?" Antibiotics 14, no. 4 (2025): 399. https://doi.org/10.3390/antibiotics14040399.
Full textShalaev, Ilya A., Oleg I. Kozhanchikov, and Natalya Yu Kozhanchikova. "Conceptual Framework and Practice of Assessment and Control of Tax Risks of Business Entities under Conditions of Changeable Tax Environment." Economic Environment 13, no. 1 (2024): 103–21. http://dx.doi.org/10.36683/ee241.103-121.
Full textSwartz, Kitt, Meredith Zauflik, Adrienne zell, Cynthia Morris, and David Ellison. "4134 Report from the research trenches: A mixed-methods approach to investigation of how recruitment methods, culture and collaboration impact clinical trial accrual." Journal of Clinical and Translational Science 4, s1 (2020): 74. http://dx.doi.org/10.1017/cts.2020.242.
Full textPrados, M., M. Gilbert, J. Kuhn, et al. "Phase I/II study of sorefenib and erlotinib for patients with recurrent glioblastoma (GBM) (NABTC 05–02)." Journal of Clinical Oncology 27, no. 15_suppl (2009): 2005. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.2005.
Full textDeng, Yi, Xiaoxi Zhang, and Qi Long. "Bayesian modeling and prediction of accrual in multi-regional clinical trials." Statistical Methods in Medical Research 26, no. 2 (2014): 752–65. http://dx.doi.org/10.1177/0962280214557581.
Full textShinkareva, O. V., and V. A. Vishnevskiy. "Features of the formation of reserves for dubious debts in tax accounting by medical organizations." Buhuchet v zdravoohranenii (Accounting in Healthcare), no. 12 (December 12, 2022): 46–53. http://dx.doi.org/10.33920/med-17-2212-05.
Full textKorn, Edward L., Boris Freidlin, Margaret Mooney, and Jeffrey S. Abrams. "Accrual Experience of National Cancer Institute Cooperative Group Phase III Trials Activated From 2000 to 2007." Journal of Clinical Oncology 28, no. 35 (2010): 5197–201. http://dx.doi.org/10.1200/jco.2010.31.5382.
Full textGuenoukpati, Agbassou, Adekunlé Akim Salami, Mawugno Koffi Kodjo, and Kossi Napo. "Estimating Weibull Parameters for Wind Energy Applications using Seven Numerical Methods: Case studies of three costal sites in West Africa." International Journal of Renewable Energy Development 9, no. 2 (2020): 217–26. http://dx.doi.org/10.14710/ijred.9.2.217-226.
Full textLiu, Junhao, Jo A. Wick, Dinesh Pal Mudaranthakam, Yu Jiang, Matthew S. Mayo, and Byron J. Gajewski. "Accrual Prediction Program: A web-based clinical trials tool for monitoring and predicting accrual for early-phase cancer studies." Clinical Trials 16, no. 6 (2019): 657–64. http://dx.doi.org/10.1177/1740774519871474.
Full textStensland, Kristian, Samuel Kaffenberger, David Canes, Matthew Galsky, Ted Skolarus, and Alireza Moinzadeh. "Assessing Genitourinary Cancer Clinical Trial Accrual Sufficiency Using Archived Trial Data." JCO Clinical Cancer Informatics, no. 4 (September 2020): 614–22. http://dx.doi.org/10.1200/cci.20.00031.
Full textWen, P. Y., T. Cloughesy, J. Kuhn, et al. "Phase I/II study of sorafenib and temsirolimus for patients with recurrent glioblastoma (GBM) (NABTC 05–02)." Journal of Clinical Oncology 27, no. 15_suppl (2009): 2006. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.2006.
Full textSchroen, A. T., G. R. Petroni, H. Wang, et al. "Challenges to accrual predictions to phase III cancer clinical trials: A survey of study chairs and lead statisticians of 248 NCI-sponsored trials." Journal of Clinical Oncology 27, no. 15_suppl (2009): 6562. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.6562.
Full textLee, Eudocia Quant, Ugonma Nnenna Chukwueke, Shawn L. Hervey-Jumper, et al. "Barriers to accrual and enrollment in brain tumor trials." Journal of Clinical Oncology 37, no. 15_suppl (2019): 2024. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.2024.
Full textSa'diyah, Dian Islamiatus, and Indrawati Yuhertiana. "Changes in the Recording of Cash-Based Accounting Methods to Accrual Base." International Journal of Community Service & Engagement 2, no. 2 (2021): 24–31. http://dx.doi.org/10.47747/ijcse.v2i2.248.
Full textRobby Gamas and Ersi Sisdianto. "Analisis Penerapan Metode Pencatatan Akuntansi Dengan Konsep Accrual Accounting Pada Perbankan Syariah." Jurnal Nuansa : Publikasi Ilmu Manajemen dan Ekonomi Syariah 2, no. 2 (2024): 92–99. http://dx.doi.org/10.61132/nuansa.v2i2.893.
Full textSuster, Michael A., Debnath Maji, Lalitha V. Nayak, et al. "A Novel Point-of-Care Whole Blood Coagulation Assay to Monitor Emicizumab Therapy in Patients with Hemophilia." Blood 132, Supplement 1 (2018): 2475. http://dx.doi.org/10.1182/blood-2018-99-113623.
Full textOpneja, Aman, Debnath Maji, Pedram Mohseni, Michael A. Suster, and Evi X. Stavrou. "Monitoring the Effects of Direct Oral Anticoagulants with a Novel Point-of-Care Sensor: Results of a Pilot Clinical Study." Blood 132, Supplement 1 (2018): 988. http://dx.doi.org/10.1182/blood-2018-99-118943.
Full textABU, E. H. "METHODS ASSESSMENT QUALITY OF ACCOUNTING REPORTING AND MODELS OF THEIR MEASUREMENT." EKONOMIKA I UPRAVLENIE: PROBLEMY, RESHENIYA 3, no. 3 (2020): 95–99. http://dx.doi.org/10.36871/ek.up.p.r.2020.03.03.018.
Full textValouch, Petr, Jaroslav Sedláček, and Peter Mokrička. "The provisions in management of risks." Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis 57, no. 6 (2009): 323–30. http://dx.doi.org/10.11118/actaun200957060323.
Full textStensland, Kristian D., Lael Suzanne Reinstatler, Alireza Moinzadeh, and Matt D. Galsky. "Identifying factors associated with poor genitourinary cancer clinical trial accrual using a novel data extraction algorithm." Journal of Clinical Oncology 37, no. 7_suppl (2019): 439. http://dx.doi.org/10.1200/jco.2019.37.7_suppl.439.
Full textDamayanti, Indri, Delfi Yandri, and Cherly Amelia. "SISTEM AKUNTANSI PENERIMAAN DAN PENGELUARAN KAS PADA ARSIP NASIONAL REPUBLIK INDONESIA." REMITTANCE: JURNAL AKUNTANSI KEUANGAN DAN PERBANKAN 4, no. 1 (2023): 71–76. http://dx.doi.org/10.56486/remittance.vol4no1.333.
Full textGordon, David Hirsch, Qianying Liu, Ben Kleinman, Theodore Karrison, Michael Kelly, and Gini F. Fleming. "Predictors of accrual success for cooperative group trials: The Cancer and Leukemia Group B (Alliance) experience." Journal of Clinical Oncology 31, no. 15_suppl (2013): TPS6645. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.tps6645.
Full textPeterson, John Stuart, Deborah Plana, Danielle Sara Bitterman, Skyler B. Johnson, and Benjamin Harris Kann. "Growth in eligibility criteria content and failure to accrue among National Cancer Institute (NCI)-affiliated clinical trials." Journal of Clinical Oncology 39, no. 15_suppl (2021): 1515. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.1515.
Full textTorabi Moghaddam, Arezo, Hossein Karbassi Yazdi, and Behrouz Basirat. "A Model for Optimizing Operating Profit Considering the Suboptimal Distribution of Production Resources with Emphasis on Accrual Items." Management Strategies and Engineering Sciences 6, no. 4 (2024): 39–48. https://doi.org/10.61838/msesj.6.4.4.
Full textMitchell, Aaron Philip, Bradford Richard Hirsch, and Amy Pickar Abernethy. "Inadequate data availability on clinical trial accrual and its effect on progress in cancer research." Journal of Clinical Oncology 31, no. 15_suppl (2013): e15572-e15572. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e15572.
Full textLee, Eudocia, Ugonma Chukwueke, Shawn Hervey-Jumper, et al. "INNV-33. BARRIERS TO ACCRUAL AND ENROLLMENT IN BRAIN TUMOR TRIALS." Neuro-Oncology 21, Supplement_6 (2019): vi137. http://dx.doi.org/10.1093/neuonc/noz175.574.
Full textWang, Ting J. (TJ). "A Conceptual Framework For The Indirect Method Of Reporting Net Cash Flow From Operating Activities." American Journal of Business Education (AJBE) 3, no. 12 (2010): 19–32. http://dx.doi.org/10.19030/ajbe.v3i12.961.
Full textYanni, Yanni, Fransiskus Randa, and Yakobus K. Bangun. "PEMAKNAAN PENERAPAN AKUNTANSI BASIS AKRUAL." AJAR 3, no. 01 (2020): 48–67. http://dx.doi.org/10.35129/ajar.v3i01.105.
Full textCohen, Daniel A., Aiyesha Dey, and Thomas Z. Lys. "Real and Accrual-Based Earnings Management in the Pre- and Post-Sarbanes-Oxley Periods." Accounting Review 83, no. 3 (2008): 757–87. http://dx.doi.org/10.2308/accr.2008.83.3.757.
Full textZang, Amy Y. "Evidence on the Trade-Off between Real Activities Manipulation and Accrual-Based Earnings Management." Accounting Review 87, no. 2 (2011): 675–703. http://dx.doi.org/10.2308/accr-10196.
Full textTate, Wendy R., Ivo Abraham, and Lee D. Cranmer. "Center-Specific Modeling Predicts Cancer Trial Accrual More Accurately Than Investigators and Random Effects Modeling at 16 Cancer Centers." JCO Clinical Cancer Informatics, no. 3 (December 2019): 1–12. http://dx.doi.org/10.1200/cci.19.00005.
Full textUrbanic, James John, Doug Case, Michelle Joy Naughton, et al. "Minority accrual on a prospective study targeting a diverse U.S. breast cancer population: An analysis of Wake Forest CCOP research base protocol 97609." Journal of Clinical Oncology 31, no. 15_suppl (2013): 6564. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.6564.
Full textTrisnawati, Rina, Mardayaningrum Mardayaningrum, and Laillatul Khotimah. "DETERMINAN MANAJEMEN LABA AKRUAL PADA INDEKS LQ45 DAN JII PERIODE 2010-2015." Riset Akuntansi dan Keuangan Indonesia 3, no. 2 (2018): 141–51. http://dx.doi.org/10.23917/reaksi.v3i2.6702.
Full text